# Johnson & Johnson (JNJ) — Q4-2017 Earnings Results

**Report date:** 2018-01-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2017

## Post-Earnings Brief

### Headline

Johnson & Johnson Misses on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.74 | N/A | -1.00% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious outlook, focusing on long-term growth despite current market pressures. They reiterated their commitment to improving operational efficiency.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized their commitment to innovation and product development.

> They acknowledged the need for strategic adjustments moving forward.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson faced some challenges in the quarter, as reflected in the EPS miss. The lack of guidance may leave investors uncertain about the company's short-term outlook. Management's cautious tone suggests they are aware of the hurdles ahead but remain focused on long-term strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2017_